Loading
Sentiment · FY2026 Q1
What companies say about each other on earnings calls — extracted verbatim from public transcripts. Mentions from the newest quarter are a Pro feature.
“Corona, Corona Extra is down more than Coors Light or Miller Lite. Never seen that before.”
An analyst notes Corona Extra is declining faster than Molson Coors' Coors Light and Miller Lite, an unusual relative-performance read-through for those brands.
“We've seen a number of food companies from PepsiCo to [ Mills ] to Kraft Heinz invest in price as part of the solution to stimulate volumes”
An analyst cites Kraft Heinz as an example of a food company investing in price to stimulate volumes.
“We've seen a number of food companies from PepsiCo to [ Mills ] to Kraft Heinz invest in price as part of the solution to stimulate volumes”
An analyst cites PepsiCo as an example of a food company investing in price to stimulate volumes in a challenged-volume category.
“And with Fever-Tree, we're just getting started. We just finished the transition last year. We're getting it into our network, and we have an excited distributor network.”
Molson Coors is early in integrating the Fever-Tree US distribution partnership, calling it its highest per-hectoliter brand with a full year of contribution in 2026 — a positive read-through for Fever-Tree's US expansion.
“We will cycle 1.9 million hectoliters of contract brewing volume in the Americas in 2025 related to Pabst and Labatt and will cycle the remaining 300,000 hectoliters in the fourth quarter.”
Molson Coors is cycling off contract-brewing volume for Labatt, winding down that customer relationship as a volume headwind to the Americas.
“We will cycle 1.9 million hectoliters of contract brewing volume in the Americas in 2025 related to Pabst and Labatt and will cycle the remaining 300,000 hectoliters in the fourth quarter.”
Molson Coors is cycling off contract-brewing volume for Pabst, a wind-down of that customer relationship that is a volume headwind to the Americas.
“if you look at what we have done with both Coca-Cola, Fever-Tree, I think we've figured out a way of working with partners to really leverage our platform”
Molson Coors cites its Coca-Cola partnership (e.g. Topo Chico, Simply licenses) as a proven model for scaling brands, implying continued collaboration value for Coca-Cola.
“We believe our partnership with Fever-Tree in the U.S. provides a strong base from which to grow our total non-alc portfolio.”
Molson Coors' U.S. distribution partnership with Fever-Tree is scaling well, a positive read-through for Fever-Tree's U.S. volumes as Molson Coors leans into non-alcoholic growth.
“while Fever-Tree is already the world's leading supplier of premium carbonated mixes with the #1 tonic and the #1 ginger beer by value in the U.S., we believe we can accelerate its growth in the U.S. over time by leveraging the scale and strength of our distribution network, combined with our marketing capabilities.”
Molson Coors positions its newly acquired Fever-Tree brand as the category-leading premium mixer supplier globally, with plans to accelerate U.S. growth by leveraging its distribution network.
“I'm very pleased with our acquisition of the U.S. business of Fever-Tree and the integration is going well, and our volumes are exceeding our expectations from a business case point of view, our distributors are excited about it.”
Molson Coors' CEO highlights strong integration progress and above-plan volumes from its recently acquired Fever-Tree U.S. mixer business, reinforcing confidence in the acquisition's strategic fit.
“Just wanted to come back to innovation and just have seen a lot of the innovation in the space skew towards higher alcohol, some little bit, maybe more exaggerated cases, things like BeatBox or BuzzBallz, but you're Simply Spiked Bold and Blue Moon Extra are moving in that direction with an 8% ABV version.”
Analyst cites BuzzBallz alongside BeatBox as part of the industry-wide shift toward higher-ABV ready-to-drink cocktails.
“Just wanted to come back to innovation and just have seen a lot of the innovation in the space skew towards higher alcohol, some little bit, maybe more exaggerated cases, things like BeatBox or BuzzBallz, but you're Simply Spiked Bold and Blue Moon Extra are moving in that direction with an 8% ABV version.”
Analyst cites BeatBox as part of a broader industry trend toward higher-ABV canned cocktails that Molson Coors is responding to with new higher-ABV innovations.
“The first, I guess along the lines of Fever-Tree, but not specifically when we think about the Yuengling deal and let's start, which is a partnership, the various partnerships with Coke, that went from partnership to ownership.”
Analyst cites the Yuengling distribution partnership with the privately-held Pennsylvania brewer as a comparable precedent for the Fever-Tree deal structure.
| Analyst | Firm | Questions (Challenge)Percentage of questions scored as challenging — where the analyst pushed back, pressed for specifics, or questioned management's assumptions. |
|---|---|---|
| Chris Carey | Wells Fargo | 6 (0%) |
| Peter Grom | UBS | 5 (0%) |
| Lauren Lieberman | Barclays | 5 (20%) |
| Eric Serotta | Morgan Stanley | 5 (20%) |
| Kevin Grundy | BNP Paribas | 5 (40%) |
| Rob Ottenstein | Evercore ISI | 5 (0%) |
| Filippo Falorni | Citigroup | 5 (0%) |
| Will Kirk | ROTH Capital Partners | 4 (25%) |
| Bonnie Herzog | Goldman Sachs | 4 (50%) |
| Kaumil Gajrawala | Jefferies | 4 (50%) |
| Firm | Analysts | Questions (Challenge)Percentage of questions scored as challenging — where the analyst pushed back, pressed for specifics, or questioned management's assumptions. |
|---|---|---|
| Wells Fargo | 1 | 6 (0%) |
| Barclays | 1 | 5 (20%) |
| BNP Paribas | 1 | 5 (40%) |
| Citigroup | 1 |
| 5 (0%) |
| Evercore ISI | 1 | 5 (0%) |
| JPMorgan | 2 | 5 (20%) |
| Bank of America | 3 | 5 (20%) |
| Morgan Stanley | 1 | 5 (20%) |
Molson Coors used its Q4 CAGNY presentation to launch Horizon 2030 under new CEO Rahul Goyal, unveiling a $450 million three-year cost savings program, a doubling of the share buyback authorization to $4 billion, and an M&A framework targeting $200-350 million deals to add 1-2% annual NSR. The company positioned 2026 as a reset year facing a $125 million incremental Midwest Premium headwind while introducing a medium-term growth algorithm of low single-digit NSR growth and high single-digit EPS growth. Core power brands retained approximately 70% of 2023 share gains, Beyond Beer approached 10% of revenue, and the value segment was elevated as a strategic priority as Goyal rewired commercial execution toward local market accountability.
Competitive Dynamics | Demand | Capital Allocation | Cost Pressure | M&A | Pricing | Macroeconomic | Margin | |
|---|---|---|---|---|---|---|---|---|
| 2024Q4 | 5 | 5 | 1 | 1 | 4 | 2 | 1 | 2 |
| 2025Q1 | 4 | 5 | 1 | 1 | 1 | 3 | 1 | 2 |
| 2025Q2 | 6 | 5 | 4 | 3 | 1 | 3 | 1 | 3 |
| 2025Q3 | 9 | 5 | 4 | 3 | 4 | 2 | ||
| 2025Q4 | 2 | 1 | 1 | 1 | 1 | |||
| 2026Q1 | 5 | 7 | 2 | 3 | 1 | 1 | 4 | 1 |
| '24Q4 | '25Q1 | '25Q2 | '25Q3 | '25Q4 | '26Q1 | |
|---|---|---|---|---|---|---|
| Competitive Dynamics | 5 | 4 | 6 | 9 | 2 | 5 |
| Demand | 5 | 5 | 5 | 5 | 1 | 7 |
| Capital Allocation | 1 | 1 | 4 | 4 | 1 | 2 |
| Cost Pressure | 1 | 1 | 3 | 3 | 1 | 3 |
| M&A | 4 | 1 | 1 | 4 | 1 | |
| Pricing | 2 | 3 | 3 | 1 | 1 | |
| Macroeconomic | 1 | 1 | 1 | 2 | 4 | |
| Margin | 2 | 2 | 3 | 1 |